Search all trials

Find therapies in clinical trials near you – page 33

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Obesity+1

Recruiting

Registered drug

Semaglutide and Granisetron for Tolerability in Overweight Adults Without Diabetes

Registered drug

Estonia

Participants:18–64 years · 65+ years
Substances:Granisetron

Contact Research Centre

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Recruiting

InvestigationalNo placebo

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:2-Isopropyl-3H-Naphtho(1,2-D)Imidazole-4,5-Dione

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drugNo placebo

Erdosteine in Patients With COPD

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Chronic spontaneous urticaria

Recruiting

InvestigationalNo placebo

Remibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Endocrine ophthalmopathy

Recruiting

InvestigationalNo placebo

AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:AMG 732

Contact Research Centre

Duchenne muscular dystrophy

Recruiting

Investigational

Duchenne Muscular Dystrophy in Patients with Gene Mutations Amenable to Exon 44 Skipping Treated with Delpacibart Zotadirsen

Investigational

Belgium

Participants:0–17 years

Contact Research Centre

Rabies

Recruiting

Registered drugNo placebo

Rabies Prophylaxis in Healthy Volunteers After Rabies Virus (Inactivated) Strain Flury LEP Vaccination

Registered drugNo placebo

Belgium

Participants:18–64 years · Healthy volunteers

Contact Research Centre

Hormone-dependent prostate cancer

Recruiting

Registered drugNo placebo

Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Neuroblastoma

Recruiting

InvestigationalNo placebo

Naxitamab Added to Standard Induction Therapy for Children and Teenagers with Newly Diagnosed High-Risk Neuroblastoma

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Naxitamab

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drug

INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Zongertinib with cisplatin or carboplatin and pemetrexed, with or without pembrolizumab, for patients with locally advanced or metastatic non-squamous non-small cell lung cancer with HER2 mutations

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Coagulation factor X level

Recruiting

InvestigationalNo placebo

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:VMX-C001

Contact Research Centre

Find therapies in clinical trials near you – page 33

10 282 trials match your criteria

Obesity+1

Semaglutide and Granisetron for Tolerability in Overweight Adults Without Diabetes

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Chronic obstructive pulmonary disease

Erdosteine in Patients With COPD

Chronic spontaneous urticaria

Remibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial

Endocrine ophthalmopathy

AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

Duchenne muscular dystrophy

Duchenne Muscular Dystrophy in Patients with Gene Mutations Amenable to Exon 44 Skipping Treated with Delpacibart Zotadirsen

Rabies

Rabies Prophylaxis in Healthy Volunteers After Rabies Virus (Inactivated) Strain Flury LEP Vaccination

Hormone-dependent prostate cancer

Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

Neuroblastoma

Naxitamab Added to Standard Induction Therapy for Children and Teenagers with Newly Diagnosed High-Risk Neuroblastoma

Colorectal cancer metastatic

INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Non-small cell lung cancer

Zongertinib with cisplatin or carboplatin and pemetrexed, with or without pembrolizumab, for patients with locally advanced or metastatic non-squamous non-small cell lung cancer with HER2 mutations

Coagulation factor X level

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.